Development and characteristics of the cellular immune response to infection with varicella-zoster virus
- PMID: 6245148
- DOI: 10.1093/infdis/141.1.7
Development and characteristics of the cellular immune response to infection with varicella-zoster virus
Abstract
Techniques for assay of in vitro lymphocyte transformation (LTF) were used with varicella-zoster virus (VZV) as the antigen to study the temporal characteristics of the VZV-specific cellular immune response in children with varicella and in normal subjects with a history of the illness. The LTF response in children with only vesicular eruptions was prompt, and individual peak activity was detected within one to two weeks after the onset of illness, followed by a gradual decrease of the activity to lower levels. Patients with a complication of meningoencephalitis showed a marked delay in the development of peak activity. No consistent defference in the development of complement-fixing antibody to VZV was observed in these patients with different clinical manifestations. The LTF response of normal subjects with remote clinical evidence of varicella was characterized by occasional high activity, a finding that suggests reinfection with VZV. These observations provide additional evidence that the specific cellular immune response is heavily involved in the pathogenesis of VZV infection.
Similar articles
-
Antibody to early antigens of varicella-zoster virus during varicella and zoster.J Infect Dis. 1979 Jul;140(1):33-41. doi: 10.1093/infdis/140.1.33. J Infect Dis. 1979. PMID: 88490
-
Immunologic evidence of reinfection with varicella-zoster virus.J Infect Dis. 1983 Aug;148(2):200-5. doi: 10.1093/infdis/148.2.200. J Infect Dis. 1983. PMID: 6310001
-
Immunity to varicella zoster virus in children with leukaemia.Med Microbiol Immunol. 1988;177(2):83-9. doi: 10.1007/BF00189529. Med Microbiol Immunol. 1988. PMID: 2834625
-
Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity.Mol Biol Med. 1989 Oct;6(5):453-62. Mol Biol Med. 1989. PMID: 2560525 Review.
-
Cell-mediated immunity to varicella-zoster virus.J Infect Dis. 1992 Aug;166 Suppl 1:S35-41. doi: 10.1093/infdis/166.supplement_1.s35. J Infect Dis. 1992. PMID: 1320649 Review.
Cited by
-
Varicella pneumonia in a bone marrow-transplanted, immune-reconstituted adenosine deaminase-deficient patient with severe combined immunodeficiency disease.J Clin Immunol. 1985 May;5(3):180-6. doi: 10.1007/BF00915509. J Clin Immunol. 1985. PMID: 2989324
-
Review: The neurobiology of varicella zoster virus infection.Neuropathol Appl Neurobiol. 2011 Aug;37(5):441-63. doi: 10.1111/j.1365-2990.2011.01167.x. Neuropathol Appl Neurobiol. 2011. PMID: 21342215 Free PMC article. Review.
-
Varicella-zoster.Handb Clin Neurol. 2014;123:265-83. doi: 10.1016/B978-0-444-53488-0.00012-2. Handb Clin Neurol. 2014. PMID: 25015490 Free PMC article. Review. No abstract available.
-
Effector and Central Memory Poly-Functional CD4(+) and CD8(+) T Cells are Boosted upon ZOSTAVAX(®) Vaccination.Front Immunol. 2015 Oct 29;6:553. doi: 10.3389/fimmu.2015.00553. eCollection 2015. Front Immunol. 2015. PMID: 26579128 Free PMC article.
-
Use of bone marrow fibroblasts to prepare targets for an HLA restricted-cytotoxicity assay system.J Clin Microbiol. 1984 Oct;20(4):696-700. doi: 10.1128/jcm.20.4.696-700.1984. J Clin Microbiol. 1984. PMID: 6490855 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous